The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

Thistlethwaite, FC; Gilham, DE; Guest, RD; Rothwell, DG; Pillai, M; Burt, DJ; Byatte, AJ; Thistlethwaite, FC; Gilham, DE; Guest, RD; Rothwell, DG; Pillai, M; Burt, DJ; Byatte, AJ; Kirillova, N; Valle, JW; Sharma, SK; Chester, KA; Westwood, NB; Halford, SER; Nabarro, S; Wan, S; Austin, E; Hawkins, RE; - view fewer (2017) The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity. Cancer Immunology, Immunotherapy 10.1007/s00262-017-2034-7 . (In press). Green open access

http://ift.tt/2ttAv1u